iso4217:GBP
xbrli:pure
xbrli:shares
iso4217:GBP
xbrli:shares
SC392467
2025-07-31
SC392467
2024-07-31
SC392467
2024-08-01
2025-07-31
SC392467
2023-08-01
2024-07-31
SC392467
bus:Director2
2024-08-01
2025-07-31
SC392467
bus:Director1
2024-08-01
2025-07-31
SC392467
bus:Director3
2024-08-01
2025-07-31
SC392467
bus:Director4
2024-08-01
2025-07-31
SC392467
bus:Director5
2024-08-01
2025-07-31
SC392467
bus:SmallEntities
2024-08-01
2025-07-31
SC392467
bus:AuditExempt-NoAccountantsReport
2024-08-01
2025-07-31
SC392467
bus:FullAccounts
2024-08-01
2025-07-31
SC392467
bus:Director1
2024-08-01
2025-07-31
SC392467
2024-08-01
2025-07-31
SC392467
bus:PrivateLimitedCompanyLtd
2024-08-01
2025-07-31
Edinburgh Science Worldwide Ltd
Registration Number SC392467 (Scotland)
Unaudited Financial Statements
for the year ended 31 July 2025
Edinburgh Science Worldwide Ltd
Notes to the Financial Statements
3 - 8
Edinburgh Science Worldwide Ltd
Registration Number
SC392467
Directors
Brendan Sweeney Dick
Mohammed Hassun Zafar (Appointed 1 August 2024)
Alastair David Milne (Resigned 21 November 2024)
Janet Marjorie Brown (Resigned 12 December 2025)
Registered Office
Harbourside House
Bankers
Bank of Scotland
The Mound
Edinburgh
EH1 1QE
Solicitor
Wright Johnston & Mackenzie LLP
Edinburgh Science Worldwide Ltd
(Registration Number SC392467)
Financial Statements for the year ended 31 July 2025
Figures in £
Notes
2025
2024
Debtors: Amounts falling due within one year
7
1,594,296
1,632,764
Cash at bank and in hand
40,702
266,515
Creditors: amounts falling due within one year
8
1,524,568
1,879,247
Net current assets
110,430
20,032
Net assets
112,052
20,032
Called up share capital
10
2
2
Profit and loss account
112,050
20,030
Shareholder's funds
112,052
20,032
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime. These financial statements and reports have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the statement of comprehensive income and retained earnings has been taken.
For the year ending 31 July 2025, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its accounts for the year ending 31 July 202 in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102.
The financial statements were approved and authorised for issue by the Board of Directors on 15 April 2026.
Signed on behalf of the Board of Directors
The notes on pages 3 to 8 form part of these accounts.
Edinburgh Science Worldwide Ltd
Financial Statements for the year ended 31 July 2025
Notes to the Financial Statements
Edinburgh Science Worldwide Ltd is a private Company limited by shares and registered in Scotland. Its principal place of business and registered office is Harbourside House, 110 Commercial Street, Edinburgh, EH6 6NF.
2.
Summary of significant accounting policies
2.1
General information and basis of preparation
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance wit Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies (see note 3).
The Company's functional and presentational currency is GBP, with amounts rounded to the nearest £.
The following principal accounting policies have been applied:
The financial statements have been prepared on a going concern basis which assumes that the Company will continue in operational existence for the foreseeable future.
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must be met before revenue is recognised.
Revenue from a contract to provide services relating to science and technology events and programmes, is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
•
the amount of revenue can be measured reliably;
•
it is probable that the Company will receive the consideration due under the contract;
•
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
•
the costs incurred and the costs to complete the contract can be measured reliably.
Donations are included as they are received, including from the parent charity.
Edinburgh Science Worldwide Ltd
Financial Statements for the year ended 31 July 2025
Notes to the Financial Statements
Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to the statement of income and retained earnings at the same rate as the depreciation on the assets to which the grant relates. The deferred element of the grant is included in creditors as deferred income.
Grants of a revenue nature are recognised in the statement of income and retained earnings in the same period as the related expenditure.
Interest income is recognised in the statement of income and retained earnings using the effective interest method.
The Company operates a defined contribution plan for its employees. A defined plan is a pension plan under which the Company pays fixed contributions into separate entity. Once the contributions have been paid the Company has no further payment obligations.
The contributions are recognised as an expense in the statement of income and retained earnings when they fall due. Amounts not paid are shown in accruals as a liability in the balance sheet. The assets of the plan are held separately from the Company in independently administered funds
Tax is recognised in the statement of income and retained earnings except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.
The charge can be eliminated by payment of a gift aid distribution within nine months following the end of the financial year.
2.8
Debtors and Creditors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
2.9
Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
Edinburgh Science Worldwide Ltd
Financial Statements for the year ended 31 July 2025
Notes to the Financial Statements
2.10
Profit and loss account
This reserve includes all current and prior periods retained profits and losses net of distributions paid.
2.11
Financial Instruments
The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
Other financial liabilities, including trade creditors, are initially measured at transaction price less transaction costs, and are subsequently measured at the transaction price less transaction costs not yet recognised in profit or loss and repayments plus cumulative interest expenses incurred.
Distributions are recognised when paid.
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at rates of exchange ruling at the balance sheet date.
Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction.
Exchange gains and losses are recognised in the statement of income and retained earnings.
3.
Judgements in applying accounting policies and key sources of estimation uncertainty
In the application of the Company's accounting policies, which are described in note 2, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underling assumtpions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
There are considered to be no key sources of estimation uncertainty.
Edinburgh Science Worldwide Ltd
Financial Statements for the year ended 31 July 2025
Notes to the Financial Statements
Charge for the year
(588)
The methods and significant assumptions applied in determining the fair value of investment property.
The extent to which the fair value of investment property (as measured or disclosed in the financial statements) is based on a valuation by an independent valuer who holds a recognised and relevant professional qualification and has recent experience in the location and class of the investment property being valued. If there has been no such valuation, that fact shall be disclosed
The following were subsidiary undertakings of the Charity:
Names
Country
Principal activity
Holding
Edinburgh Science Worldwide Holdings Ltd (SC802990)
Scotland
Holding company
100%
Edinburgh Science US
USA
Organiser of commercial science festival projects
100%
Edinburgh Science Worldwide Ltd
Financial Statements for the year ended 31 July 2025
Notes to the Financial Statements
Amounts falling due within one year
£
£
Trade debtors
1,825
10,000
Prepayments and accrued income
-
117,552
Amounts owed by group undertakings
1,592,459
1,505,212
Amounts owed by group undertakings are unsecured, interest free and repayable on demand.
8.
Creditors: amounts falling due within one year
Creditors: amounts falling due within one year comprise:
2024
2023
2023
Trade creditors
2,517
527,300
Other creditors
248
7,930
Accruals and deferred income
18,900
29,754
Amounts owed to group undertakings
1,402,664
1,262,554
Value added tax
50,240
51,709
Amounts owed to group undertakings are unsecured, interest free and repayable on demand.
9.
Deferred tax assets where utilisation is dependent on future taxable profits
The company has an unrecognised deferred tax asset of £ (2024:£29,966) which has arisen from losses carried forward. Its recoverability is dependent upon future profits arising, the likelihood of which cannot at this stage be determined with reasonable certainty.
10.
Called up share capital
Alloted, called up and fully paid
2 (2024: 2) Ordinary shares of £1.00 each
11.
Related party transactions
As a wholly owned subsiduary of the Edinburgh Science Foundation Ltd, a charitable Company registered in Scotland, advantage has been taken of the exemption granted by the Financial Reporting Standard 102 not to report details of the transactions with the entities that are 100% controlled by a common parent undertaking.
Edinburgh Science Worldwide Ltd
Financial Statements for the year ended 31 July 2025
Notes to the Financial Statements
The Company's ultimate parent undertaking is Edinburgh Science Foundation Ltd, a charitable Company registered in Scotland, which is the smallest and largest group of companies for which group financial statements are prepared. Copies of the group financial statements are available to the public from Companies House.
The registered office of Edinburgh Science Foundation Ltd is Harbourside House, 110 Commercial Street, Edinburgh, EH6 6NF
In the directors' opinion, the parent undertaking has no ultimate controlling party.
Appendix - Additional XBRL Tags and Values
Accounting standards applied
Accounts status, audited or unaudited
Average number of employees during the period
Average number of employees during the period
Date of authorisation of financial statements for issue
Director signing Directors' Report
Director signing financial statements
End date for period covered by report
Entity current legal or registered name
Edinburgh Science Worldwide Ltd
Entity is dormant [true/false]
Equity [Multiple Tags or Values]
Equity [Multiple Tags or Values]
Name of individual auditor
Name of production software
Start date for period covered by report
UK Companies House registered number
Version of production software